Phase I Study of Tumor Necrosis Factor Plus Actinomycin D in Patients with Androgenindependent Prostate Cancer
Author:
Publisher
Mary Ann Liebert Inc
Subject
Cancer Research,Pharmacology
Link
http://www.liebertpub.com/doi/pdf/10.1089/cbr.1995.10.225
Reference15 articles.
1. Tumor Necrosis Factor: A Potential Antitumor Agent?
2. Tumor necrosis factor activities and cancer therapy — A perspective
3. Schedule-Dependent Toxicity of Tumor Necrosis Factor in Rodents
4. Tumor Necrosis Factor Enhances the in Vitro and in Vivo Efficacy of Chemotherapeutic Drugs Targeted at DNA Topoisomerase II in the Treatment of Murine Bladder Cancer
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology;Prostate Cancer;2012
2. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells;International Immunopharmacology;2006-09
3. Tumor Vascular Targeting with Tumor Necrosis Factor and Chemotherapeutic Drugs;Annals of the New York Academy of Sciences;2004-12-01
4. Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity;Nature Biotechnology;2003-03-31
5. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration;Journal of Clinical Investigation;2002-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3